Immuron’s CEO Steven Lydeamore will present at Peak’s Management Conference and highlight:
💊 Therapeutic drug candidates
📔 Product portfolio
👊 Outlook
Watch the full interview ⚡ https://youtu.be/HkgvbT3cRu8
ERA
0.003
50%
PRX
0.002
-33.3%
4DX
0.795
39.5%
IFG
0.028
-24.3%
S2R
0.125
33%
PKD
0.027
-20.6%
ATV
0.029
26.1%
DEL
0.125
-19.4%
DRE
0.015
25%
OSX
0.01
-16.7%
VRC
0.005
25%
TAR
0.01
-16.7%
RRR
0.099
23.8%
GCM
0.023
-14.8%
RUL
4.64
23.1%
ALM
0.006
-14.3%
BCM
0.028
21.7%
ENT
0.006
-14.3%
FDR
0.14
21.7%
ENV
0.006
-14.3%
ARV
0.006
20%
ETM
0.072
-14.3%
RLG
0.006
20%
M4M
0.006
-14.3%
SNS
0.048
20%
OMG
0.012
-14.3%
HHR
0.007
16.7%
SPX
0.006
-14.3%
RCM
0.036
16.1%
BXN
0.043
-14%
SNG
0.076
15.2%
PPK
0.452
-13.9%
T92
0.054
14.9%
M2M
0.019
-13.6%
CRS
0.11
14.6%
AER
0.06
-13%
ADD
0.032
14.3%
RAG
0.02
-13%
LMS
0.125
13.6%
CDX
0.027
-12.9%
